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ABSTRACT
OBJECTIVE: To analyze the factors associated with late presentation to HIV/AIDS services 
among heterosexual men. 
METHODS: Men infected by HIV who self-identified as heterosexual (n = 543) were included 
in the study. Descriptive, biivariate and logistic regression analyses were performed to evaluate 
the factors associated with late presentation (defined as individuals whose first CD4 count was 
<350 cells/mm3) in the study population.
RESULTS: The prevalence of late presentation was 69.8%. The multivariate logistic analysis 
showed testing initiated by the provider (ORadjusted 3.75; 95%CI 2.45–5.63) increased the odds of 
late presentation. History of drug use (ORadjusted 0.59; 95%CI 0.38–0.91), history of having sexually 
transmitted infections (ORadjusted 0.64; 95%CI 0.42–0.97), and having less education (ORadjusted 0.63; 
95%CI 0.41–0.97) were associated with a decreased odds of LP.
CONCLUSIONS: Provider initiated testing was the only variable to increase the odds of late 
presentation. Since the patients in this sample all self-identified as heterosexual, it appears that 
providers are not requesting they be tested for HIV until the patients are already presenting 
symptoms of AIDS. The high prevalence of late presentation provides additional evidence to 
shift towards routine testing and linkage to care, rather than risk-based strategies that may not 
effectively or efficiently engage individuals infected with HIV.
DESCRIPTORS: Men’s Health. Heterosexual. Acquired Immunodeficiency Syndrome. 
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INTRODUCTION
Globally, studies have documented unprotected receptive anal intercourse (URAI) as an important 
risk factor for the transmission of HIV3. Consequently, men who self-identify as heterosexual are 
often overlooked in efforts to address HIV/AIDS, as it is assumed that they are not engaging in 
URAI. However, recent literature has documented high numbers of heterosexual men presenting 
to care with low CD4 cell counts12,17. Commonly referred to as late presentation (LP) to care2, data 
from high-income countries show the prevalence of LP to range between 52.5% and 67.2%8,15,20-23.. 
Less is known about the prevalence in middle or low-income countries, but studies from 
Brazil – one of the first countries to guarantee free, universal antiretroviral (ARV) since 1996 in 
the Brazilian Unified Health System (SUS) and an expected associated opportunity to improve 
access to care – have shown the prevalence ranging from 43.6% to 54.0%10,18. 
Studies noted an association between men who self-identify as heterosexual and LP 
globally3,4,6,8,19 and in Brazil10, but few of these studies identified the factors specifically 
associated with LP among this population. In the general population, LP is more frequent 
among males4,8,23, older adults4,5,11-15,25, and immigrants5,11,13,15,23,25. Fewer studies have assessed 
predictors of LP by sexual identity, more often focusing on sexual behavior. However, 
recognizing that same-sex behavior is often stigmatized, and that patients may not be willing 
to disclose behavior to their medical providers, identifying factors associated with LP by 
self-reported sexual identity could be useful to clinicians who must rely on patient report. 
Thus, the research question of this study was to identify the prevalence and predictors of LP among 
self-identified heterosexual men (hereafter referred to as heterosexual men) living with HIV. 
We explored LP among heterosexual men in Brazil, an upper middle-income country often 
considered a global model of success for their response to HIV with one of the largest 
antiretroviral treatment programs in the world, to expand the knowledge regarding this 
important public health issue in the care cascade for HIV/AIDS.
METHODS 
In this cross-sectional study, we collected data on 1,970 participants (men = 1,056 and 
women = 914) in Northeast Brazil. All participants were HIV-infected (confirmed by 
laboratory diagnosis), aged 18 years or older, and enrolled for clinical care for the first time 
at one of three main health facilities in Salvador, BA, Northeastern Brazil, from August 2010 
to June 2011. Responding to growing evidence in the peer-reviewed literature that men who 
identify as heterosexual present increased risk for LP, we limited our analysis to all men who 
self-identified as heterosexual (n = 591) to the question on sexual identity. 
The facilities included the public HIV/AIDS specialty care center and two large public hospitals 
providing general and HIV/AIDS outpatient care. Since 1997, the Brazilian government has 
provided HIV/AIDS care and treatment free of charge at all facilities belonging to the SUS. 
The facilities were located in Salvador, a large urban center of Brazil, capital of Bahia, and 
the third most populous (approximately 2.7 million people) and poorest city in the country. 
The study staff attended the HIV specialty care center and the HIV outpatient care at the 
two hospitals daily. A list of scheduled patients was provided to the study team beforehand. 
Refusal to participate was minimal (less than 5.0%). All patients were counseled that the 
participation in the study entailed responding to our survey and allowing access to their 
laboratory data. Further, the participants were asked to sign an informed consent form. 
The interviews were individually conducted in a private space at the facility with trained 
research staff. Data were collected by oral interviews. Patients were asked a range of questions, 
and responses were recorded using a palm pilot. The interview addressed comprehensive 
questions on sociodemographic characteristics, access to HIV/AIDS services, as well as 
sexual and other behaviors associated with LP. No financial incentives were provided.
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The outcome variable, LP, was based on the consensus statement released by the 
European Late Presenter Group, which defined LP as individuals with a CD4 cell count 
< 350 cells per mm3 or symptoms of AIDS-defining illnesses, or both2. Here, LP was restricted 
to individuals with available CD4 cell count because we lacked data to identify individuals 
defined as an AIDS case based on clinical symptoms. As a result, 9.2% men were excluded, 
reducing the sample size to n = 543. A subanalysis confirmed that individuals with no 
clinical data were similar to the sample population. To complete and validate data on 
the first CD4 cell count, trained research assistants used information from hand written 
clinical records and from the Sistema de Controle de Exames Laboratoriais da Rede Nacional 
de Contagem de Linfócitos CD4+/CD8+ e Carga Viral (SISCEL – Laboratory Test Control 
System of the Brazilian Network of CD4+/CD8+ T Lymphocyte and Viral Load Count) 
national database. This system is organized by patient identifier code and the database 
is powered by a nationwide network of reference laboratories10.
Key variables to the study of LP were explored. Age was dichotomized based on the traditional 
cut point for reproductive age (18-44 years versus 45-86 years). Skin color was categorized 
into black, brown, and white, yellow, indigenous, and other. The remaining sociodemographic 
variables were dichotomized as follows: individual income (comparing individuals receiving 
minimum wage of BRL510.00 per month = USD328.11 per month or less to individuals 
receiving above it); employment (comparing individuals formally and informally employed to 
individuals who were unemployed); and years of schooling (comparing individuals receiving 
the minimum eight years of schooling required by the Brazilian government to individuals 
receiving more). Regarding other factors associated with LP in the peer-reviewed literature, 
we examined reasons for taking an HIV test (comparing individuals requesting an HIV test 
to individuals who were requested by their provider to test for HIV); perceived risk for HIV 
transmission (yes; no); history of drug use (comparing individuals who already reported 
drug use to individuals who never reported drug use); number of sexual partners in the 
last 12 months (comparing individuals reporting one or less to individuals reporting more); 
and history of sexually transmitted infection (STI) (comparing individuals who never had a 
diagnosed STI to individuals who had a diagnosed STI at least once). 
Figure. Distribution and average CD4 count for men who self-identify as heterosexual, by age groups 
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Descriptive and bivariate analyses were conducted and statistically significant variables 
(determined by the 95% confidence interval – CI of the odds ratio – OR) were included 
in the final multiple logistic regression analysis along with key variables highlighted in 
the literature. We used logistic regression analyses with adjusted odds ratios (AOR) to 
evaluate the independent effect of potential explanatory variables and model diagnostics 
tests to examine associations and outliers. The analyses used the Stata software, version 
12. The goodness of fit of the model was verified by the Hosmer-Lemeshow chi-square 
test, comparing the expected frequencies with the observed frequency (p = 0.35), which 
indicated that the model fits the data well. The area under the ROC curve of 0.71 showed 
acceptable discrimination between LP and not LP. The model also showed good agreement 
(72.50) and high sensitivity (92.1).
The Research Ethics Committee of the Bahia State Secretariat of Health and of Harvard 
School of Public Health approved this study.
Table 1. Descriptive data of men self-identified as heterosexual receiving HIV/AIDS care in Brazil.
Variable
Men who self-identify as heterosexual
(n = 543)
n %
CD4 cell count at presentation to care
< 350 cells/mm3 379 69.8
≥ 350 cells/mm3 164 30.2
Reported sexual practice
Reported sex with women only 285 52.5







White, Yellow, Indigenous, or other 112 20.6
Individual income*
> Minimum wage 415 76.4





> 8 years 237 43.7
≤ 8 years 306 56.3
Reason for taking an HIV test
Patient requested the HIV test/Other 203 37.4




History of drug use
No 373 68.7
Yes 170 31.3
Number of sexual partners in the last 12 months
≤ One 329 63.8
> One 187 36.2
History of STI
Never 322 59.9
At least once 216 40.1
STI: sexually transmitted infections
* Minimum wage of BRL510.00 per month (USD328.11 in 2011), as established by the Brazilian government.
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RESULTS 
The prevalence of LP based on the consensus definition was 69.8% among heterosexual men. 
The prevalence of individuals with CD4 below 200 was 50.1%. Of note, 86.1% presented a 
CD4 count ≤ 500 cells/mm3, the new threshold for treatment initiation in Brazil since 2013. 
In terms of the distribution of initial CD4 counts, the Figure shows that the average CD4 
count was 322 cells/mm3 for men in reproductive age, compared to 244 cells/mm3 among 
men aged 45 and older. 
Full descriptive statistics are reported in Table 1. In our sample, 47.0% self-identified as brown, 
33.0% as black, and 21.0% as white, yellow, indigenous, or other. Just over half of respondents 
were 44 years old or younger. Half of respondents were employed, and 76.0% reported an 
income above the official minimum wage. Nearly half of respondents had completed more 
than eight years of education. Further, 69.0% and 60.0% reported no history of drug use and 
STI, respectively. Approximately 36.0% of all respondents reported having more than one 
sexual partner in the past 12 months. 
Table 2. Number, proportion and odds ratio of late presentation among men self-identified as heterosexual 
receiving HIV/AIDS care in Brazil. 
Variable
Late presentation among men who 
self-identify as heterosexual
n % OR 95%CI
Reported sexual practice
Reported sex with women only 200 70.2 1.00
Reported sex with women and men 179 69.4 0.96 0.67–1.39
Age (years)
18-44 214 69.3 1.00
45-86 165 56.6 1.06 0.73–1.54
Skin color
Brown 171 67.6 1.00
Black 126 71.2 1.18 0.78–1.80
White, Yellow, Indigenous, or other 81 72.3 1.25 0.77–2.05
Individual Income*
> Minimum wage 290 70.0 1.00
≤ Minimum wage 89 69.5 0.98 0.64–1.51
Employment
Employed 175 64.8 1.00
Unemployed 203 74.6 1.60 1.10–2.32
Years of schooling
> 8 years 172 72.6 1.00
≤ 8 years 207 67.7 0.79 0.41–0.89
Reason for taking an HIV test
Patient requested the HIV test/Other 104 51.2 1.00
Provider requested the HIV test 275 80.9 4.02 2.68–6.05
Perceived HIV risk
No 123 64.1 1.00
Yes 254 73.0 1.52 1.04–2.22
History of drug use
No 273 73.2 1.00
Yes 106 62.4 0.61 0.41–0.89
Number sexual partners in the last 12 months
≤ One 234 71.1 1.00
> One 126 67.4 0.84 0.57–1.24
History of STI
Never 235 73.0 1.00
At least once 140 64.8 0.68 0.57–1.23
STI: sexually transmitted infections
* Minimum wage of BRL510.00 per month (USD328.11 in 2011), as established by the Brazilian government.
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The bivariate results highlighted several variables associated with LP (Table 2). Individuals 
who were unemployed (OR = 1.60; 95%CI 1.10–2.32), whose provider requested they be 
tested for HIV (OR = 4.02; 95%CI 2.68–6.05), and who perceived they were at risk for HIV 
(OR = 1.52; 95%CI 1.04–2.22) were all associated with increased odds for LP. In contrast, 
individuals reporting less education (OR = 0.79; 95%CI 0.41–0.89) and history of drug use 
(OR = 0.61; 95%CI 0.41–0.89) were associated with a decreased risk for LP.
Table 3 shows the multiple logistic regression results. Once controlling for additional 
variables of interest, provider-initiated testing was the only variable to increase the odds for 
LP (OR = 3.82; 95%CI 2.49–5.85). Having a history of drug use (OR = 0.58, 95%CI 0.37–0.91) 
or past STI (OR = 0.62, 95%CI 0.40–0.95), and reporting less education (OR = 0.63, 95%CI 
0.41–0.97) were associated with decreased odds for LP.
DISCUSSION
The analysis highlighted that provider-initiated testing was associated with increased odds 
for LP among heterosexual men, while experience with drug use, history of STI, and lower 
levels of education decreased the odds for LP.
The prevalence of LP among heterosexual men in our sample was similar to levels observed 
by Mocroft et al.17 in the COHERE study (66.1%) and by Iwuji et al.12 in the UK (68.8%), which 
appears higher than noted in the global literature in studies on the general population, found 
Table 3. Predictors of late presentation: adjusted odds ratios and 95%CI of late presentation among 
men self-identified as heterosexual receiving HIV/AIDS care in Brazil.
Variable
Late presentation among men who 
self-identify as heterosexual
n % OR 95%CI
Reported sexual practice
Reported sex with women only 200 70.2 1.00
Reported sex with women and men 179 69.4 1.51 0.85–2.69
Age (years)
18-44 214 69.3 1.00
45-86 165 70.5 0.93 0.60–1.42
Skin color
Brown 171 67.6 1.00
Black 126 71.2 1.58 0.98–2.53
White, Yellow, Indigenous, or other 81 72.3 1.23 0.71–2.13
Employment
Employed 175 64.8 1.00
Unemployed 203 74.6 1.52 0.99–2.31
Years of schooling
> 8 172 72.6 1.00
≤ 8 207 67.7 0.63 0.41–0.97
Reason for taking an HIV test
Patient requested the HIV test/Other 104 51.2 1.00
Provider requested the HIV test 275 80.9 3.82 2.49–5.85
Perceived HIV risk
No 298 72.5 1.00
Yes 80 61.5 0.87 0.54–1.41
History of drug use
No 273 73.2 1.00
Yes 106 62.4 0.58 0.37–0.91
Number sexual partners in the last 12 months
≤ One 234 71.1 1.00
> One 126 67.4 0.67 0.37–1.20
History of sexually transmitted infection
Never 235 73.0 1.00
At least once 140 64.8 0.62 0.40–0.95
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between 38.0% and 59.0%1,5,7,8,19,24,25. This could be due to the fact that our analysis is limited to 
men and several studies have noted that being male is associated with a higher risk for LP18, 
as women are more commonly tested during prenatal care and likely linked to care with a 
higher CD4 count compared to individuals testing for HIV only upon showing symptoms of 
opportunistic infections associated with HIV. The high prevalence of LP provides additional 
evidence to shift towards routine testing and linkage to care, rather than risk-based strategies 
that might not effectively or efficiently engage individuals infected with HIV. 
The results highlighted that the provider-initiated testing, compared to patient-initiated 
testing, was associated with an increased odds ratio for LP. Given that Brazil has a 
concentrated epidemic, individuals are not referred for testing unless they present HIV or 
AIDS-related symptoms or report specific behaviors known to increase their risk of HIV 
transmission. Since all patients in this sample self-identified as heterosexual, it appears 
that providers are not requesting them to be tested for HIV until the patients are already 
presenting symptoms of AIDS. These results further suggest that testing should shift away 
from a risk-based strategy, as it likely ignores individuals who may not openly report certain 
behaviors traditionally associated with an increased risk of transmission.
Several variables were associated with decreased odds for LP. Experience with drug use 
has been shown in the global literature to be associated with an increased risk for LP7-9,13,19. 
However, one study that distinguished the stage in the HIV care to which individuals 
presented late found that drug users were more likely to be tested and less likely to present 
to care9. This suggests that more specific information, such as data related to late testing, 
enrollment, and treatment, may be needed to accurately identify to which service an 
individual is presenting late; also, individuals aware of their risk for HIV might be more likely 
to engage in HIV-related care, which was confirmed with our results, though the effect was 
not statistically significant in the multiple logistic regression. 
Having been diagnosed with STI in the past was also associated with decreased odds for LP. 
This is likely related to the fact that individuals with a diagnosed STI have already come in 
contact with a service provider and therefore are more aware of their risk for HIV compared 
to other individuals16. This reflects how previous engagement with health services can impact 
LP. While professionals discuss how to organize and integrate HIV care with other health 
services, our results showed that the engagement with care, broadly defined, may improve 
the timing with which services are accessed. 
We also observed that individuals with less education experienced slightly decreased odds 
for LP. This finding is counterintuitive, especially in light of our results that highlight how the 
awareness of risk for HIV can decrease the odds for LP. It is possible that the data reflects an 
underlying difference in the sample population. Since the study was conducted at a public 
clinic, it serves as the primary source of care for more marginalized individuals, whereas 
individuals who can afford private care do not seek services in the public sector until they 
need to access treatment. Without having access to data from privately funded facilities, we 
are unable to test this hypothesis. Consequently, the relationship between education and 
HIV risk is complex and warrants further exploration in subsequent research. 
In sum, the prevalence of LP is alarmingly high among heterosexual men in our study. 
Though they are not traditionally viewed as a key population, these results suggest that they 
often fall off the radar of both policymakers and providers, and therefore represent a missed 
opportunity for timely presentation to care. Also, shifting from a risk-based to a routine 
strategy for HIV testing could help to engage people in care, with HIV testing as only the 
first, albeit crucial, step of linking into continued HIV care. More generally, the data showed 
that knowledge of potential risk for HIV may serve as an important driver for individuals 
to seek available services.
Concerning the study limitations, the outcome measure focuses exclusively on CD4 count, 
and therefore it remains unclear to which service the patient is presenting late. However, 
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since it continues to be the consensus definition of LP, we agreed it provided a useful marker 
for evaluating LP to HIV services more generally. Further, given the cross-sectional nature 
of the study design, the results cannot be generalized to the Brazilian population nor can 
the causality be determined. Going forward more specific and nuanced data would help to 
better understand how the receipt of specific HIV services impacted the odds of presenting 
to care. At last, there is evidence to suggest that self-reported sexual orientation might not be 
consistent with the sexual practices of an individual. Nonetheless, it is critically important 
to report the risk factors associated with self-reported sexual orientation, as providers must 
be aware of the potential risks among their patients who identify as heterosexual males. 
Therefore, research must continue to investigate if the potential risks for LP may differ based 
on how patients present themselves to their provider.
Regarding its substantial strengths, to our knowledge, this is one of the only studies to 
exclusively focus on heterosexual men and show factors associated with LP in this population. 
This study provides important insight regarding factors associated with men who self-identify 
as heterosexual, a population continually overlooked in HIV prevention and treatment 
efforts. Further, this study has a large sample size and gives insight to the effectiveness of 
one of the world’s largest treatment programs for people living with HIV/AIDS. Finally, this 
is one of the few articles focusing on LP outside of a high-income context and suggests 
that the longstanding availability of prevention and treatment might not translate into the 
utilization of services. 
In conclusion, the factors associated with LP among heterosexual men were the following: 
provider-initiated testing was associated with increased odds for LP while experience with 
drug use, history of STI, and lower levels of education decreased the odds for LP. These 
results highlight the importance of considering how a continued focus on the concept of key 
populations may miss a range of individuals in need of HIV testing and continued access to 
HIV services to achieve viral suppression. This study suggests that expanding the reach of 
HIV testing might help to identify and engage those who otherwise remain invisible.
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